臨床質譜分析市場按產品類型、應用、最終用戶和地區分類

Clinical Mass Spectrometry Market, By Product Type, By Application, By End User, By Geography

出版日期: 2026年01月19日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

臨床質譜市場預計在 2026 年達到 44.4 億美元，預計到 2033 年將達到 67.6 億美元，2026 年至 2033 年的複合年成長率為 6.14%。

報告覆蓋範圍		報告詳情
基準年：	2025	2026年市場規模：	44.4億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	6.14%	2033 年的預測值：	67.6億美元

臨床質譜技術在藥物研發和個人化醫療中發揮著至關重要的作用。它也被用於生物組織樣本的生物成像，以檢測生物標記。降低成本和提高檢測品質是推動質譜技術普及應用的主要因素。據美國臨床化學協會 (AACC) 稱，液相層析法質譜聯用 (LC-MS) 的高特異性使其能夠檢測內源性睪固酮水平低的患者體內的睪固酮水平。該技術比傳統的免疫檢測更可靠，尤其適用於女性和兒童。這促使研究實驗室儘早採用基於成熟技術的最新一代儀器。

臨床診斷質譜儀能夠同時分析有限範圍的樣本，例如生物標記、蛋白質和藥物分子，並且能夠分析低濃度樣本。

這包括低濃度。因此，這些儀器是診斷和實驗室環境中的寶貴工具。此外，它們還使研究人員能夠確定微量給藥的藥物的藥物動力學特徵。由於高解析度技術（例如四極飛行時間以及對這類光譜技術的需求預計將迅速成長。

市場動態

預計主要企業的技術創新和產品推出將推動臨床質譜市場的成長。技術進步包括質譜儀的小型化和分析單元自動化程度的提高，從而減少人工操作並提高儀器效率。例如，賽默飛世爾科技於2017年6月發布了一款全自動分析儀，可客製化以相容於實驗室資訊系統。

本次調查的主要特點

本報告以 2025 年為基準年，對預測期（2026-2033 年）內全球臨床質譜市場規模進行了詳細分析。
我們重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業的競爭策略的重要見解。
該報告根據以下參數對全球臨床質譜市場的主要參與者進行了分析：公司概況、財務表現、產品系列、地理分佈、主要發展和策略。
本報告的研究結果將使企業負責人和經營團隊能夠就未來的產品發布、政府舉措、市場擴張和行銷策略做出明智的決策。
這份全球臨床質譜分析報告的目標受眾是該行業的各種相關人員，包括投資者、產品製造商、經銷商、臨床質譜儀供應商、研究和諮詢公司、新參與企業和金融分析師。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 日本
- 印度
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
非洲
- 北非
- 中非
- 南非
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家

第8章競爭情勢

公司簡介
- Bruker Corporations
- Kore Technologies
- Bergman Messgerate Entwicklung KG
- Mass Spectrometry Instruments（MSI）
- RGB Photonics
- ABLE Biosciences
- Thermo Fisher Scientific Inc.
- Danaher Corporations
- Agilent Technologies
- Shimadzu Corporation
- PerkinElmer Inc.

第9章各節

參考
調查方法

簡介目錄

Product Code: CMI193

Clinical Mass Spectrometry Market is estimated to be valued at USD 4.44 Bn in 2026 and is expected to reach USD 6.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.14% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.14%	2033 Value Projection:	USD 6.76 Bn

Clinical mass spectrometry plays a vital role in the drug discovery pipeline for development of personalized medicines. It is further used in live imaging of biological tissue samples for detection of biomarkers. Cost reduction and improved assay quality are the key factors driving the adoption of mass spectrometry technique. According to the American Association for Clinical Chemistry (AACC), the greater specificity of liquid chromatography-mass spectrometry (LC-MS) enables the measuring of testosterone in the patients with low endogenous concentrations. This technique is more reliable than traditional immunoassays, especially in women and children. This has led to an early adoption of the most recent generation of instruments using an established technology in the laboratories.

Clinical diagnostic mass spectrometers have the potential to analyze limited range of samples such as biomarkers, proteins or drug molecules at once, and in

Some cases with low concentrations. Thus, these devices are a valuable tool in diagnostics and laboratory settings. Furthermore, it allows researchers to determine pharmacokinetic profiles of drugs that are administered in micro doses. The technology shift from traditional systems to high-resolution technologies such as Quadrupole-time of flight (Q-TOF) mass spectrometry and the demand for this spectrometry technique type is expected to grow rapidly owing to advantages such as accuracy, improved resolution, and sensitivity for clinical diagnostic applications.

Market Dynamics

Technological advancements and product launches by key players are expected to drive growth of the clinical mass spectrometry market. Advancements in technology include miniaturization of mass spectrometry instruments and increasing automation within spectrometric units to reduce human efforts and improve efficiency of the instrument. For instance, a fully automated analyzer launched by Thermo Fisher, in June 2017 that can be customized for compatibility with laboratory information systems.

Key features of the study

This report provides in-depth analysis of the global clinical mass spectrometry market size (US$ Mn), and compound annual growth rate (CAGR (%)) over the forecast period: 2026 - 2033, considering 2025 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global clinical mass spectrometry market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
Key players covered as a part of this study include Bruker Corporation Kore Technology Limited, Bergman Messgerate Entwicklung KG, Mass Spectrometry Instruments (MSI), Thermo Fisher Scientific Inc., Agilent Technologies, and Danaher Corporations
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, market expansion, and marketing tactics
The global clinical mass spectrometry report caters to various stakeholders in this industry which include investors, product manufacturers, distributors, and suppliers of clinical mass spectrometry, research and consulting firms, new entrants, and financial analysts.

Market Segmentation

By Product Type
- Gas chromatography-mass spectrometry (GC-MS) instrument
- Liquid chromatography-mass spectrometry (LC-MS) instrument
- Maldi TOF mass spectrometer
- Capillary electrophoresis-mass spectrometry
- Ion mobility spectrometry-mass spectrometry
By Application
- Clinical Testing
- Proteomics
- Drug Discovery
By End User
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Clinical Mass Spectrometry Market - Competitive Landscape
- Bruker Corporation
- Kore Technology Limited
- Bergman Messgerate Entwicklung KG
- Mass Spectrometry Instruments (MSI)
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Danaher Corporations

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Porter's Five Forces Model

4. Global Clinical Mass Spectrometry Market, By Product Type, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2017 - 2033
- Segment Trends
Gas chromatography-mass spectrometry (GC-MS) instrument
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Liquid chromatography-mass spectrometry (LC-MS) instrument
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Maldi TOF mass spectrometer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Capillary electrophoresis-mass spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Ion mobility spectrometry-mass spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

5. Global Clinical Mass Spectrometry Market, By Application, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2017 - 2033
- Segment Trends
Clinical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

6. Global Clinical Mass Spectrometry Market, By End User, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2017 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)

7. Global Clinical Mass Spectrometry Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2018- 2033
- Regional Trends
North America
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Africa
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa
Middle East
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East

8. Competitive Landscape

Company Profiles
- Bruker Corporations
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Kore Technologies
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Bergman Messgerate Entwicklung KG
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Mass Spectrometry Instruments (MSI)
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- RGB Photonics
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- ABLE Biosciences
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Danaher Corporations
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Agilent Technologies
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Shimadzu Corporation
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- PerkinElmer Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views